• / Free eNewsletters & Magazine
  • / My Account
Home>Funds>Ishares S And P S>iShares S&P S/T Natnl AMT-Free Muni Bd

Related Topics

  1. Summit Bancorp
  2. Becton
  3. iShares iBoxx High Yield Corporate Bd
  4. iShares
  5. iShares S&P U.S. Preferred Stock Index
  6. iShares S&P 100 Index

Popular Topics

  1. Deutsche Bank
  2. Emerging Markets
  3. Stock Market
  4. Dow Jones
  5. Unemployment Rate

iShares S&P S/T Natnl AMT-Free Muni Bd

iShares S&P National AMT-Free Muni Bd MUB 3 Star

Last Price$106.51Day Change (%)0%
Open Price$107.00Day Change ($)0.00
Day Range106.43–107.0952-Week Range106.40–114.52

As of Tue 06/18/2013 07:12 PM EDT | USD

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  6. Research
  1. Digital China Announces FY2012/13 Annual Results

    Digital China Announces FY2012/13 Annual Results

  2. Lockheed Martin Selects Marotta Controls to Develop Power Conditioning Unit for Modernized M299 Launcher

    Lockheed Martin Selects Marotta Controls to Develop Power Conditioning Unit for Modernized M299 Launcher

  3. UPDATE Adobe 2nd-Quarter Profit Down 66% as Expenses Rise

    UPDATE Adobe 2nd-Quarter Profit Down 66% as Expenses Rise

  4. Adobe Profit Down 66% as Expenses Rise

    Adobe Profit Down 66% as Expenses Rise

  5. Defense Firms Will Stay Aloft

    Industry faces short-term challenges, but discipline and strong balance sheets will get companies through.

  6. Dassault Systèmes Launches “Co-Design to Target,” a New Industry Solution Experience for Aerospace & Defense Programs

    Dassault Systèmes Launches “Co-Design to Target,” a New Industry Solution Experience for Aerospace & Defense Programs

  7. Research and Markets: US Nutraceuticals Market Forecast to 2017

    Research and Markets: US Nutraceuticals Market Forecast to 2017

  8. Fitch: Cost Initiatives Counter Slow Growth Prospects for U.S. Corporates

    Fitch: Cost Initiatives Counter Slow Growth Prospects for U.S. Corporates

  9. New EXTEND Analyses Evaluate Efficacy of Single Agent PIXUVRI® in 3rd and 4th Line Salvage Setting With and Without Prior Rituximab Treatment

    New EXTEND Analyses Evaluate Efficacy of Single Agent PIXUVRI® in 3rd and 4th Line Salvage Setting With and Without Prior Rituximab Treatment

  10. Zoetis Set to Join S&P 500; First Horizon National to Join S&P MidCap 400; QLogic to Join S&P SmallCap 600

    Zoetis Set to Join S&P 500; First Horizon National to Join S&P MidCap 400; QLogic to Join S&P SmallCap 600

12345…
Our Products
Tools
Resources
Services
Upcoming Events
Conferences
Webinars

©2012 Morningstar Advisor. All right reserved.